FDA Inspection
Fresenius Kabi USA LLCFresenius Kabi USA LLC – FDA Inspection, Jun 30, 2022
Record Details
This FDA Inspection record concerns Fresenius Kabi USA LLC, with an inspection on June 30, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Fresenius Kabi USA LLC
- Inspection Date
- June 30, 2022
- Product Type
- Drugs
View Company Profile
ID · 840588fe-a12c-4d6a-9e65-ebef63b1314e
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1174894
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Fresenius Kabi USA LLC
14| Date | Classification | Office | Project area |
|---|---|---|---|
| February 18, 2026 | Not classified | Chicago District Office | |
| August 24, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 18, 2020 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 3, 2018 | NAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
| September 18, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Fresenius Kabi USA LLC
- FDA Inspection 1311592 - 2026-02-18
- FDA Inspection 1216183 - 2023-08-24
- FDA Inspection 1123748 - 2020-05-18
- FDA Inspection 1075139 - 2018-12-03
- FDA Inspection 943126 - 2015-09-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.